These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12809085)

  • 1. Pharmaco-electroencephalography in Phase I.
    Luthringer R; Boeijinga PH
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():95. PubMed ID: 12809085
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps.
    Danhof M; Visser SA
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():127-8. PubMed ID: 12585231
    [No Abstract]   [Full Text] [Related]  

  • 3. Can pharmaco-electroencephalography help improve survival of central nervous system drugs in early clinical development?
    Wilson FJ; Leiser SC; Ivarsson M; Christensen SR; Bastlund JF
    Drug Discov Today; 2014 Mar; 19(3):282-8. PubMed ID: 23954252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary psychometric methods in pharmaco-electroencephalography research.
    Emegbo S; Hindmarch I
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():13. PubMed ID: 12809078
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical Decision Tree: a tool for studying pharmaco-EEG effects of CNS-active drugs.
    Dago KT; Luthringer R; Lengellé R; Rinaudo G; Macher JP
    Neuropsychobiology; 1994; 29(2):91-6. PubMed ID: 8170530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.
    Barbanoj MJ; Valle M; Kulisevsky J; Pérez V; Gambús P
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():139-44. PubMed ID: 12575481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in neuroscience.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):26-7. PubMed ID: 12625023
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaco-EEG: from cellular to the network level. EEG beta spectral power as a biomarker for GABAergic inhibition and its role in the assessment of AEDs.
    Lopes da Silva F
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():3. PubMed ID: 12575462
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the 12th Meeting of the International Pharmaco-EEG Group. Barcelona, Spain, November 21-24, 2002.
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():1-181. PubMed ID: 12852399
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the 12th Meeting of the International Pharmaco-EEG Group--training course. Barcelona, Spain, November 21-24, 2002.
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():1-142. PubMed ID: 12852400
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaco-EEG Studies in Animals: An Overview of Contemporary Translational Applications.
    Drinkenburg WH; Ruigt GS; Ahnaou A
    Neuropsychobiology; 2015; 72(3-4):151-64. PubMed ID: 26901596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [[Plant excipients--valuable pharmaceutical aids or superfluous ballast?] ].
    Eder M; Mehnert W
    Pharm Unserer Zeit; 2000 Nov; 29(6):377-84. PubMed ID: 11199915
    [No Abstract]   [Full Text] [Related]  

  • 14. ONO-2506. Ono.
    de Paulis T
    Curr Opin Investig Drugs; 2003 Jul; 4(7):863-7. PubMed ID: 14619409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of designs and doses for early phase trials.
    Zhou Y
    Fundam Clin Pharmacol; 2004 Jun; 18(3):373-8. PubMed ID: 15147290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of functional imaging across clinical phases in CNS drug development.
    Borsook D; Becerra L; Fava M
    Transl Psychiatry; 2013 Jul; 3(7):e282. PubMed ID: 23860483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 1 clinical trials: not just for safety anymore?
    Khandekar J; Khandekar M
    Arch Intern Med; 2006 Jul; 166(14):1440-1. PubMed ID: 16864752
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal pharmaco-EEG: models, facts and fallacies.
    Ruigt GS
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():59-61. PubMed ID: 12575469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.